$OM

Osisko Metals Announces Conversion of Glencore Canada's US$25 Million Convertible Debenture

Osisko Metals (TSX: OM) said Glencore Canada converted its US$25 million senior secured convertible debenture into 88,962,500 units at C$0.40 per unit, plus interest conversion into 6,862,444 units at C$1.58 per unit. Glencore Canada also exercised warrants cashlessly, issuing 32,301,860 shares. TSX approval remains pending.

Original reporting
Published Jul 13, 2026, 9:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 13, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Osisko Metals Announces Conversion of Glencore Canada's US$25 Million Convertible Debenture — source image
Decision brief

The 30-second read

$OMNeutralMed
01

Why it matters

Glencore Canada exercised conversion on a cashless basis for the principal portion, issuing 88,962,500 common shares and 44,481,250 warrants, plus additional shares from accrued interest conversion. Resulting ownership rises to about 14.4% non-diluted and 14.7% partially diluted (assuming warrant exercise).

02

Market read

This is a concrete capital-structure update with specific share and warrant issuance, conversion pricing, and a new strategic ownership stake.

03

What to watch

Warrant exercise is cashless for the initial-principal warrants, but the remaining interest warrants expire Aug 7, 2026; traders should watch for any subsequent warrant exercises and TSX approval timing.

Relevance 7/10Novelty 7/10Timing: today’s disclosure of debenture conversion and warrant exercise mechanics, pending TSX final approval

Background

Osisko Metals issued a US$25M senior secured convertible debenture dated July 14, 2023, held by Glencore Canada.

Company-level read

Ticker impact

$OMNeutralMedium confidence
Context

Osisko Metals says Glencore Canada converted a US$25M convertible debenture into 88,962,500 shares plus warrants, pending TSX approval.

Expected impact

Near-term volatility possible around dilution math and ownership signaling; direction depends on whether the market views the conversion as supportive financing versus dilution.

Evidence & confidence

The article provides concrete issuance quantities, conversion prices, and resulting ownership percentages, but does not include guidance, project updates, or a stated change in fundamentals beyond capital structure.

Market effects

Signals ongoing financing and capital-structure management in Canadian critical-metals exploration, where convertibles and warrants are common.

Could affect TSX/OTCQX/Frankfurt liquidity and positioning for OM as ownership concentration rises.

Limited global read-through; primarily a company-specific capital structure event.

Counterpoint

The conversion could be interpreted as Glencore de-risking its instrument into equity while retaining warrant exposure, which may be viewed as confidence in the asset rather than distress.

Key entities

  • Osisko Metals Incorporated

    Canadian exploration and development company; subject of the convertible debenture conversion announcement.

  • Glencore Canada Corporation

    Holder of the US$25M senior secured convertible debenture that converted into OM equity and warrants.

  • Toronto Stock Exchange (TSX)

    Final approval required for the conversion to be completed.

Related articles

$OMMedAI 8/10

Outset Medical (OM) Q2 2026 Earnings Call Transcript

Outset Medical (OM) reported Q2 2026 revenue of $31.6 million, up 1% year over year and 14% sequentially. Console revenue was $9.5 million, up 6% YoY, while product revenue fell 5% to $21.9 million. Non-GAAP gross margin was 42.2%. Cash and investments were $151 million. Full-year revenue guidance is $125 million to $130 million.

$OMMed

Outset Medical Reports Second Quarter 2026 Results

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Outset Medical Reports Second Quarter 2026 Results San Jose, CA – August 6, 2026 – Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today

$AEMMed

Tuesday’s analyst upgrades and downgrades

National Bank Financial analysts revised precious-metals and copper forecasts ahead of Q2 earnings, citing realized gold at $4,508/oz and silver at $73/oz, and copper at $5.82/lb. They cut 2026 gold and silver assumptions and adjusted target prices for multiple miners, generally lower. TD Cowen upgraded First Quantum Minerals on a likely Cobre Panama restart by year-end.

$OMMed

Outset Medical, Inc. (OM): Results of Operations and Financial Condition

Outset Medical, Inc. (OM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-10.1 2 om-ex10_1.htm EX-10.1 EX-10.1 Exhibit 10.1 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) THE TYPE OF INFORMATION THA

$OMMedAI 8/10

Osisko logs 3. 49 % copper at Gaspé project in Quebec

Osisko Metals (TSX: OM) began its 2026 drilling at the Gaspé copper project in Quebec, aiming to add mineralization within the planned Whittle pit. It reported hole 30-1196: 80m at 1.93% Cu from 196m, including 30m at 3.49% Cu from 224m. Scotia Capital said intercepts fall in modelled waste rock, potentially supporting resource conversion.